{
    "hands_on_practices": [
        {
            "introduction": "This exercise sharpens skills in evidence-based medicine by moving from abstract data to a concrete clinical decision. We will first derive the performance characteristics—sensitivity, specificity, and likelihood ratios—of key imaging modalities for Placenta Accreta Spectrum (PAS). Subsequently, we will apply Bayesian reasoning to update a specific patient's risk, a core skill in modern obstetrics that quantitatively integrates new diagnostic information to refine clinical judgment .",
            "id": "4417958",
            "problem": "In the setting of planned complex cesarean delivery with potential cesarean hysterectomy, accurate antenatal diagnosis of Placenta Accreta Spectrum (PAS) is critical for surgical planning, resource allocation, and hemorrhage risk mitigation. Consider two diagnostic modalities commonly used in PAS evaluation: Ultrasonography (US) and Magnetic Resonance Imaging (MRI). The following study cohorts, abstracted from published summaries, report performance against the reference standard of histopathology:\n\nFor Ultrasonography (US):\n- Among $1{,}000$ individuals suspected of PAS, histopathology confirmed PAS in $200$. US yielded $170$ positive results among those with PAS and $30$ negative results among those with PAS. Among the $800$ without PAS, US yielded $56$ positive results and $744$ negative results.\n\nFor Magnetic Resonance Imaging (MRI):\n- Among $1{,}000$ individuals with similar risk profiles, histopathology confirmed PAS in $150$. MRI yielded $135$ positive results among those with PAS and $15$ negative results among those with PAS. Among the $850$ without PAS, MRI yielded $128$ positive results and $722$ negative results.\n\nA patient presents with placenta previa and two prior cesarean deliveries. Based on epidemiologic risk stratification, her pre-test probability of PAS is $0.40$. She undergoes both tests. US is positive, and MRI is negative. Assume, for the purpose of this calculation, that conditional independence holds between US and MRI given disease status and given non-disease status.\n\nStarting only from the core definitions of sensitivity, specificity, probability, and odds, and using the data provided above, do the following:\n1. Derive the sensitivity and specificity for US and for MRI.\n2. From these, derive the positive and negative likelihood ratios for US and for MRI.\n3. Using the odds form of Bayesian updating grounded in the definitions above, compute the patient’s final post-test probability of PAS after sequential application of the US result (positive) followed by the MRI result (negative) under the stated independence assumption.\n\nExpress the final post-test probability as a decimal rounded to four significant figures. No unit is required.",
            "solution": "The problem statement is validated as scientifically grounded, well-posed, objective, and self-contained. All data and conditions necessary for a unique solution are provided. The problem is a standard application of diagnostic test evaluation and Bayesian inference within a realistic clinical context. Therefore, a full solution is warranted.\n\nLet $D+$ represent the presence of a Placenta Accreta Spectrum (PAS) condition, and $D-$ represent its absence. Let $T_{US}+$ and $T_{US}-$ denote positive and negative results from Ultrasonography (US), respectively. Similarly, let $T_{MRI}+$ and $T_{MRI}-$ denote positive and negative results from Magnetic Resonance Imaging (MRI).\n\nThe problem requires a three-part calculation: first, the derivation of sensitivity and specificity for each test; second, the derivation of the corresponding likelihood ratios; and third, the application of Bayesian updating to find the final post-test probability for a specific patient.\n\n**Part 1: Sensitivity and Specificity**\n\nThe fundamental performance characteristics of a diagnostic test are its sensitivity and specificity.\n\nSensitivity ($Se$) is the probability that the test is positive given that the individual has the disease: $Se = P(T+|D+)$. It is calculated from the number of true positives ($TP$) and false negatives ($FN$) as $Se = \\frac{TP}{TP + FN}$.\n\nSpecificity ($Sp$) is the probability that the test is negative given that the individual does not have the disease: $Sp = P(T-|D-)$. It is calculated from the number of true negatives ($TN$) and false positives ($FP$) as $Sp = \\frac{TN}{FP + TN}$.\n\nFrom the provided data for Ultrasonography (US):\n-   Number with PAS ($D+$): $N_{US, D+} = 200$.\n-   True Positives ($TP_{US}$): $170$.\n-   False Negatives ($FN_{US}$): $30$.\n-   Number without PAS ($D-$): $N_{US, D-} = 800$.\n-   False Positives ($FP_{US}$): $56$.\n-   True Negatives ($TN_{US}$): $744$.\n\nThe sensitivity and specificity for US are:\n$$Se_{US} = \\frac{TP_{US}}{TP_{US} + FN_{US}} = \\frac{170}{170 + 30} = \\frac{170}{200} = 0.85$$\n$$Sp_{US} = \\frac{TN_{US}}{FP_{US} + TN_{US}} = \\frac{744}{56 + 744} = \\frac{744}{800} = 0.93$$\n\nFrom the provided data for Magnetic Resonance Imaging (MRI):\n-   Number with PAS ($D+$): $N_{MRI, D+} = 150$.\n-   True Positives ($TP_{MRI}$): $135$.\n-   False Negatives ($FN_{MRI}$): $15$.\n-   Number without PAS ($D-$): $N_{MRI, D-} = 850$.\n-   False Positives ($FP_{MRI}$): $128$.\n-   True Negatives ($TN_{MRI}$): $722$.\n\nThe sensitivity and specificity for MRI are:\n$$Se_{MRI} = \\frac{TP_{MRI}}{TP_{MRI} + FN_{MRI}} = \\frac{135}{135 + 15} = \\frac{135}{150} = 0.90$$\n$$Sp_{MRI} = \\frac{TN_{MRI}}{FP_{MRI} + TN_{MRI}} = \\frac{722}{128 + 722} = \\frac{722}{850} = \\frac{361}{425} \\approx 0.8494$$\n\n**Part 2: Positive and Negative Likelihood Ratios**\n\nLikelihood Ratios (LRs) quantify how much a given test result increases or decreases the odds of having the disease.\n\nThe Positive Likelihood Ratio ($LR+$) is the ratio of the probability of a positive test in a diseased individual to the probability of a positive test in a non-diseased individual. It is derived from sensitivity and specificity as $LR+ = \\frac{P(T+|D+)}{P(T+|D-)} = \\frac{Se}{1-Sp}$.\n\nThe Negative Likelihood Ratio ($LR-$) is the ratio of the probability of a negative test in a diseased individual to the probability of a negative test in a non-diseased individual. It is derived as $LR- = \\frac{P(T-|D+)}{P(T-|D-)} = \\frac{1-Se}{Sp}$.\n\nFor US, using $Se_{US} = 0.85$ and $Sp_{US} = 0.93$:\n$$LR+_{US} = \\frac{Se_{US}}{1 - Sp_{US}} = \\frac{0.85}{1 - 0.93} = \\frac{0.85}{0.07} = \\frac{85}{7}$$\n$$LR-_{US} = \\frac{1 - Se_{US}}{Sp_{US}} = \\frac{1 - 0.85}{0.93} = \\frac{0.15}{0.93} = \\frac{15}{93} = \\frac{5}{31}$$\n\nFor MRI, using $Se_{MRI} = 0.90$ and $Sp_{MRI} = \\frac{722}{850}$:\n$$LR+_{MRI} = \\frac{Se_{MRI}}{1 - Sp_{MRI}} = \\frac{0.90}{1 - \\frac{722}{850}} = \\frac{0.90}{\\frac{128}{850}} = \\frac{9}{10} \\times \\frac{850}{128} = \\frac{9 \\times 85}{128} = \\frac{765}{128}$$\nThe patient had a negative MRI, so we need the $LR-_{MRI}$:\n$$LR-_{MRI} = \\frac{1 - Se_{MRI}}{Sp_{MRI}} = \\frac{1 - 0.90}{\\frac{722}{850}} = \\frac{0.10}{\\frac{722}{850}} = \\frac{1}{10} \\times \\frac{850}{722} = \\frac{85}{722}$$\n\n**Part 3: Bayesian Updating to Compute Post-Test Probability**\n\nThe odds form of Bayes' theorem states that the post-test odds of a disease are the product of the pre-test odds and the likelihood ratio for the observed test result: $O_{post} = O_{pre} \\times LR$.\n\nProbability ($P$) and odds ($O$) are related by the equations $O = \\frac{P}{1-P}$ and $P = \\frac{O}{1+O}$.\n\nThe patient's pre-test probability of PAS is given as $P_{pre}(D+) = 0.40$.\nFirst, we convert this to pre-test odds:\n$$O_{pre} = \\frac{P_{pre}(D+)}{1 - P_{pre}(D+)} = \\frac{0.40}{1 - 0.40} = \\frac{0.40}{0.60} = \\frac{2}{3}$$\n\nThe patient has a positive US result ($T_{US}+$) and a negative MRI result ($T_{MRI}-$). The problem states to assume conditional independence between the tests given the disease status. This allows for sequential updating of the odds. The final post-test odds, $O_{final}$, can be calculated by multiplying the pre-test odds by the likelihood ratio for each test result:\n$$O_{final} = O_{pre} \\times LR+_{US} \\times LR-_{MRI}$$\n\nSubstituting the calculated values:\n$$O_{final} = \\frac{2}{3} \\times \\frac{85}{7} \\times \\frac{85}{722}$$\n$$O_{final} = \\frac{2 \\times 85 \\times 85}{3 \\times 7 \\times 722} = \\frac{14450}{15162} = \\frac{7225}{7581}$$\n\nFinally, we convert the final post-test odds back to a probability, $P_{final}(D+)$:\n$$P_{final}(D+) = \\frac{O_{final}}{1 + O_{final}} = \\frac{\\frac{7225}{7581}}{1 + \\frac{7225}{7581}} = \\frac{\\frac{7225}{7581}}{\\frac{7581 + 7225}{7581}} = \\frac{7225}{14806}$$\n\nTo obtain the final numerical answer, we perform the division and round to four significant figures:\n$$P_{final}(D+) = \\frac{7225}{14806} \\approx 0.4879778...$$\nRounding to four significant figures gives $0.4880$.\n\nThus, after a positive US and a negative MRI, the patient's probability of having PAS is approximately $0.4880$. The positive US result substantially increased her risk from a baseline of $0.40$, and the subsequent negative MRI result decreased it, but the net effect is an overall increase in the final probability.",
            "answer": "$$\\boxed{0.4880}$$"
        },
        {
            "introduction": "Successful management of a complex cesarean hysterectomy hinges on proactive preparation, especially for the high risk of massive hemorrhage. This practice guides you through the essential calculations for planning blood product availability, translating a predicted blood loss into a specific, actionable order for the blood bank . You will apply fundamental principles of transfusion medicine to ensure a balanced resuscitation can be initiated without delay, linking preoperative assessment directly to intraoperative readiness.",
            "id": "4417892",
            "problem": "A multidisciplinary team is preparing for a planned cesarean delivery with immediate cesarean hysterectomy for placenta percreta. The anesthesia and blood bank teams request a quantitative plan for blood products to have immediately available in a balanced massive transfusion framework.\n\nAssume the following scientifically grounded facts and definitions, all of which may be taken as given for this calculation:\n\n- Maternal blood volume at term is approximated by $85\\,\\mathrm{mL/kg}$.\n- The patient’s weight is $70\\,\\mathrm{kg}$ and her preoperative hematocrit is $0.33$.\n- Predicted blood loss for this case is $6000\\,\\mathrm{mL}$.\n- One unit of packed red blood cells (PRBC) contains $300\\,\\mathrm{mL}$ with a unit hematocrit of $0.55$; thus each PRBC unit contains $165\\,\\mathrm{mL}$ of red cell volume.\n- One unit of fresh frozen plasma (FFP) is $250\\,\\mathrm{mL}$.\n- One apheresis platelet unit (platelets) is equivalent to six pooled random donor platelet units and is the platelet unit used in massive transfusion.\n- For balanced resuscitation, define one massive transfusion protocol pack as a $1{:}1{:}1$ “unit-equivalent” pack: $6$ PRBC units, $6$ FFP units, and $1$ apheresis platelet unit.\n- Cryoprecipitate (cryo) contains $250\\,\\mathrm{mg}$ fibrinogen per unit and is dispensed in pools of $10$ units.\n- Without cryoprecipitate, the predicted fibrinogen nadir during resuscitation is $C_{p} = 2.25\\,\\mathrm{g/L}$; the target to maintain is $C_{t} = 3.00\\,\\mathrm{g/L}$. The baseline fibrinogen is $C_{0} = 3.50\\,\\mathrm{g/L}$.\n\nUsing first principles, compute:\n\n1) The minimum number of PRBC units required to replace the red cell volume lost from the predicted hemorrhage.\n\n2) The numbers of FFP units and apheresis platelet units to have available by staging complete massive transfusion protocol packs so that the PRBC requirement is met without falling short, maintaining the defined $1{:}1{:}1$ unit-equivalent ratio.\n\n3) The number of cryoprecipitate units required to raise the fibrinogen concentration from $C_{p}$ to $C_{t}$, using the patient’s plasma volume derived from maternal blood volume and preoperative hematocrit, and then the smallest integer number of $10$-unit pools that meets or exceeds this requirement.\n\nExpress your final answer as a row vector in the order PRBC units, FFP units, apheresis platelet units, cryoprecipitate units. Report integer counts for all components. If any intermediate calculation yields a non-integer number of units, plan for the smallest integer number that meets or exceeds the calculated need. No additional rounding by significant figures is required beyond this indivisible unit constraint. No units should appear in the final boxed answer.",
            "solution": "The problem is valid as it is scientifically grounded, well-posed, and objective. It provides a set of consistent physiological parameters and blood product specifications to quantitatively determine the required number of blood product units for a specific high-risk surgical procedure. The calculations are based on fundamental principles of hematology and transfusion medicine.\n\nThe solution is computed in three parts as requested.\n\n**1) Minimum Number of Packed Red Blood Cells (PRBC) Units**\n\nFirst, we calculate the total volume of red cells lost due to the predicted hemorrhage. The predicted blood loss is $V_{loss} = 6000\\,\\mathrm{mL}$, and the patient's preoperative hematocrit is $Hct_0 = 0.33$. The volume of red cells lost, $V_{RC,lost}$, is the product of these two values.\n$$V_{RC,lost} = V_{loss} \\times Hct_0 = 6000\\,\\mathrm{mL} \\times 0.33 = 1980\\,\\mathrm{mL}$$\nEach unit of PRBC contains a red cell volume of $V_{RC,unit} = 165\\,\\mathrm{mL}$. The minimum number of PRBC units, $N_{PRBC,min}$, required to replace the lost red cell volume is the ratio of the total red cell volume lost to the red cell volume per unit.\n$$N_{PRBC,min} = \\frac{V_{RC,lost}}{V_{RC,unit}} = \\frac{1980\\,\\mathrm{mL}}{165\\,\\mathrm{mL/unit}} = 12\\,\\mathrm{units}$$\nSince this is an integer, the minimum number of PRBC units required is exactly $12$.\n\n**2) Fresh Frozen Plasma (FFP) and Apheresis Platelet Units**\n\nThe problem specifies that blood products are to be staged in complete massive transfusion protocol (MTP) packs to meet the PRBC requirement. Each MTP pack is defined as containing $6$ PRBC units, $6$ FFP units, and $1$ apheresis platelet unit.\n\nTo meet or exceed the minimum requirement of $N_{PRBC,min} = 12$ units, we calculate the number of MTP packs, $N_{packs}$, required.\n$$N_{packs} = \\left\\lceil \\frac{N_{PRBC,min}}{6\\,\\mathrm{units/pack}} \\right\\rceil = \\left\\lceil \\frac{12}{6} \\right\\rceil = \\lceil 2 \\rceil = 2\\,\\mathrm{packs}$$\nStaging $2$ complete MTP packs will provide the necessary components while maintaining the desired $1{:}1{:}1$ unit-equivalent ratio. The total number of units for each component will be:\n-   Number of PRBC units: $N_{PRBC} = N_{packs} \\times 6 = 2 \\times 6 = 12\\,\\mathrm{units}$. This exactly meets the calculated minimum requirement.\n-   Number of FFP units: $N_{FFP} = N_{packs} \\times 6 = 2 \\times 6 = 12\\,\\mathrm{units}$.\n-   Number of apheresis platelet units: $N_{platelets} = N_{packs} \\times 1 = 2 \\times 1 = 2\\,\\mathrm{units}$.\n\n**3) Cryoprecipitate Units**\n\nTo calculate the cryoprecipitate requirement, we must first determine the patient's plasma volume, $V_{plasma}$, which is the volume of distribution for fibrinogen. The patient's total blood volume, $V_{TBV}$, is approximated using her weight, $W = 70\\,\\mathrm{kg}$, and the term pregnancy value of $85\\,\\mathrm{mL/kg}$.\n$$V_{TBV} = W \\times 85\\,\\mathrm{mL/kg} = 70\\,\\mathrm{kg} \\times 85\\,\\mathrm{mL/kg} = 5950\\,\\mathrm{mL}$$\nThe plasma volume is the fraction of total blood volume that is not red cells, determined by the preoperative hematocrit $Hct_0 = 0.33$.\n$$V_{plasma} = V_{TBV} \\times (1 - Hct_0) = 5950\\,\\mathrm{mL} \\times (1 - 0.33) = 5950\\,\\mathrm{mL} \\times 0.67 = 3986.5\\,\\mathrm{mL}$$\nFor calculation with concentrations given in grams per liter, we convert the plasma volume to liters:\n$$V_{plasma} = 3.9865\\,\\mathrm{L}$$\nThe goal is to raise the fibrinogen concentration from the predicted nadir, $C_p = 2.25\\,\\mathrm{g/L}$, to the target, $C_t = 3.00\\,\\mathrm{g/L}$. The required increase in concentration is $\\Delta C = C_t - C_p$.\n$$\\Delta C = 3.00\\,\\mathrm{g/L} - 2.25\\,\\mathrm{g/L} = 0.75\\,\\mathrm{g/L}$$\nThe total mass of fibrinogen required, $M_{deficit}$, is the product of the concentration change and the plasma volume.\n$$M_{deficit} = \\Delta C \\times V_{plasma} = 0.75\\,\\mathrm{g/L} \\times 3.9865\\,\\mathrm{L} = 2.989875\\,\\mathrm{g}$$\nEach unit of cryoprecipitate contains $M_{fib,unit} = 250\\,\\mathrm{mg}$ of fibrinogen, which is equivalent to $0.250\\,\\mathrm{g}$. The number of cryoprecipitate units needed, $N_{cryo,calc}$, is:\n$$N_{cryo,calc} = \\frac{M_{deficit}}{M_{fib,unit}} = \\frac{2.989875\\,\\mathrm{g}}{0.250\\,\\mathrm{g/unit}} = 11.9595\\,\\mathrm{units}$$\nSince units are indivisible, we must round up to the next whole number to meet the requirement.\n$$N_{cryo,min} = \\lceil 11.9595 \\rceil = 12\\,\\mathrm{units}$$\nCryoprecipitate is dispensed in pools of $10$ units. To obtain at least $12$ units, we must acquire a sufficient number of pools, $N_{pools}$.\n$$N_{pools} = \\left\\lceil \\frac{N_{cryo,min}}{10\\,\\mathrm{units/pool}} \\right\\rceil = \\left\\lceil \\frac{12}{10} \\right\\rceil = \\lceil 1.2 \\rceil = 2\\,\\mathrm{pools}$$\nThe total number of cryoprecipitate units to have available is the total content of these pools.\n$$N_{cryo} = N_{pools} \\times 10\\,\\mathrm{units/pool} = 2 \\times 10 = 20\\,\\mathrm{units}$$\n\nThe final answer is composed of the four integer counts for PRBCs, FFPs, apheresis platelets, and cryoprecipitate.\n- PRBC units: $12$\n- FFP units: $12$\n- Apheresis platelet units: $2$\n- Cryoprecipitate units: $20$",
            "answer": "$$\\boxed{\\begin{pmatrix} 12 & 12 & 2 & 20 \\end{pmatrix}}$$"
        },
        {
            "introduction": "Massive transfusion, while life-saving, introduces its own set of metabolic challenges, most notably citrate-induced hypocalcemia which impairs cardiac function and coagulation. This exercise simulates a critical intraoperative scenario where you must rapidly calculate the precise amount of calcium needed to both correct an existing deficit and neutralize the ongoing citrate load from transfused products . This practice demonstrates the quantitative approach required for dynamic physiological management in real-time during a surgical crisis.",
            "id": "4417913",
            "problem": "A patient undergoing cesarean hysterectomy for placenta accreta spectrum develops hemorrhage requiring massive transfusion. Over the most recent $30\\,\\mathrm{min}$, she received $4$ units of packed red blood cells (PRBC), $2$ units of fresh frozen plasma (FFP), and $1$ apheresis platelet unit. For the purposes of immediate calcium replacement during this interval, use the following effective citrate loads per unit reaching the systemic circulation on this time scale: PRBC $= 1.2\\,\\mathrm{mmol}$ per unit, FFP $= 3.0\\,\\mathrm{mmol}$ per unit, apheresis platelets $= 2.0\\,\\mathrm{mmol}$ per unit. Assume that, acutely, a fraction $f = 0.40$ of the infused citrate remains available to chelate calcium and that citrate chelates calcium with an effective $1{:}1$ molar stoichiometry in plasma on this time scale. Her measured ionized calcium (iCa) is $0.95\\,\\mathrm{mmol/L}$, and the target iCa is $1.10\\,\\mathrm{mmol/L}$.\n\nAssume that the ionized calcium rapidly distributes throughout the extracellular fluid (ECF), approximated as $0.20$ of body mass. Her body mass is $70\\,\\mathrm{kg}$, and endogenous calcium homeostatic responses are negligible over the immediate dosing interval.\n\nYou have $10\\%$ calcium gluconate, with each $10\\,\\mathrm{mL}$ ampule containing $2.25\\,\\mathrm{mmol}$ of elemental calcium. Using conservation of mass and the above assumptions, compute the single bolus volume of $10\\%$ calcium gluconate (in $\\mathrm{mL}$) required now to both neutralize the acute citrate chelation sink and raise the plasma iCa from $0.95\\,\\mathrm{mmol/L}$ to $1.10\\,\\mathrm{mmol/L}$.\n\nExpress your final dosing volume in $\\mathrm{mL}$ and round your answer to three significant figures.",
            "solution": "The problem requires the calculation of the volume of a $10\\%$ calcium gluconate solution needed to correct hypocalcemia in a patient experiencing hemorrhage and receiving a massive transfusion. The total calcium deficit is composed of two components: the amount of calcium chelated by citrate from transfused blood products, and the amount needed to raise the patient's measured ionized calcium concentration to a target level within its distribution volume. The calculation proceeds by applying the principle of conservation of mass.\n\nFirst, we calculate the total molar quantity of citrate infused over the $30\\,\\mathrm{min}$ interval.\nLet $N_{\\text{PRBC}}$, $N_{\\text{FFP}}$, and $N_{\\text{plt}}$ be the number of units of packed red blood cells, fresh frozen plasma, and apheresis platelets administered, respectively.\nLet $L_{\\text{PRBC}}$, $L_{\\text{FFP}}$, and $L_{\\text{plt}}$ be the effective citrate load per unit for each product.\nThe given values are:\n$N_{\\text{PRBC}} = 4$\n$N_{\\text{FFP}} = 2$\n$N_{\\text{plt}} = 1$\n$L_{\\text{PRBC}} = 1.2\\,\\mathrm{mmol/unit}$\n$L_{\\text{FFP}} = 3.0\\,\\mathrm{mmol/unit}$\n$L_{\\text{plt}} = 2.0\\,\\mathrm{mmol/unit}$\n\nThe total infused citrate load, $M_{\\text{cit,total}}$, is the sum of the loads from each product:\n$$M_{\\text{cit,total}} = (N_{\\text{PRBC}} \\times L_{\\text{PRBC}}) + (N_{\\text{FFP}} \\times L_{\\text{FFP}}) + (N_{\\text{plt}} \\times L_{\\text{plt}})$$\n$$M_{\\text{cit,total}} = (4 \\times 1.2\\,\\mathrm{mmol}) + (2 \\times 3.0\\,\\mathrm{mmol}) + (1 \\times 2.0\\,\\mathrm{mmol})$$\n$$M_{\\text{cit,total}} = 4.8\\,\\mathrm{mmol} + 6.0\\,\\mathrm{mmol} + 2.0\\,\\mathrm{mmol} = 12.8\\,\\mathrm{mmol}$$\n\nSecond, we determine the amount of this citrate that actively chelates calcium. A fraction $f = 0.40$ of the infused citrate is assumed to be available for chelation. The effective molar amount of chelating citrate, $M_{\\text{cit,eff}}$, is:\n$$M_{\\text{cit,eff}} = f \\times M_{\\text{cit,total}} = 0.40 \\times 12.8\\,\\mathrm{mmol} = 5.12\\,\\mathrm{mmol}$$\nAccording to the problem, citrate chelates calcium with an effective $1{:}1$ molar stoichiometry. Therefore, the amount of calcium chelated and effectively removed from the ionized pool, $\\Delta M_{\\text{Ca,chel}}$, is equal to the effective molar amount of citrate.\n$$\\Delta M_{\\text{Ca,chel}} = M_{\\text{cit,eff}} = 5.12\\,\\mathrm{mmol}$$\nThis represents the first component of the total calcium deficit.\n\nThird, we calculate the amount of calcium needed to raise the ionized calcium concentration in the extracellular fluid (ECF) from the measured value to the target value. The volume of distribution for ionized calcium is the ECF, which is given as $20\\%$ of the patient's body mass.\nThe patient's body mass is $M_b = 70\\,\\mathrm{kg}$. The ECF volume, $V_{\\text{ECF}}$, is:\n$$V_{\\text{ECF}} = 0.20 \\times M_b = 0.20 \\times 70\\,\\mathrm{kg} \\approx 14\\,\\mathrm{L}$$\n(assuming the density of ECF is approximately $1\\,\\mathrm{kg/L}$).\n\nThe measured ionized calcium is $[\\text{iCa}]_{\\text{current}} = 0.95\\,\\mathrm{mmol/L}$, and the target is $[\\text{iCa}]_{\\text{target}} = 1.10\\,\\mathrm{mmol/L}$. The required increase in concentration, $\\Delta[\\text{iCa}]$, is:\n$$\\Delta[\\text{iCa}] = [\\text{iCa}]_{\\text{target}} - [\\text{iCa}]_{\\text{current}} = 1.10\\,\\mathrm{mmol/L} - 0.95\\,\\mathrm{mmol/L} = 0.15\\,\\mathrm{mmol/L}$$\nThe molar amount of calcium required to achieve this increase across the ECF volume, $\\Delta M_{\\text{Ca,ECF}}$, is:\n$$\\Delta M_{\\text{Ca,ECF}} = \\Delta[\\text{iCa}] \\times V_{\\text{ECF}} = 0.15\\,\\mathrm{mmol/L} \\times 14\\,\\mathrm{L} = 2.1\\,\\mathrm{mmol}$$\nThis represents the second component of the total calcium deficit.\n\nFourth, the total molar amount of elemental calcium that must be administered, $\\Delta M_{\\text{Ca,total}}$, is the sum of the two deficits:\n$$\\Delta M_{\\text{Ca,total}} = \\Delta M_{\\text{Ca,chel}} + \\Delta M_{\\text{Ca,ECF}}$$\n$$\\Delta M_{\\text{Ca,total}} = 5.12\\,\\mathrm{mmol} + 2.1\\,\\mathrm{mmol} = 7.22\\,\\mathrm{mmol}$$\n\nFinally, we calculate the volume of $10\\%$ calcium gluconate solution required to deliver this amount of calcium. The problem states that each $10\\,\\mathrm{mL}$ ampule contains $2.25\\,\\mathrm{mmol}$ of elemental calcium. The concentration of elemental calcium in the solution, $C_{\\text{Ca}}$, is:\n$$C_{\\text{Ca}} = \\frac{2.25\\,\\mathrm{mmol}}{10\\,\\mathrm{mL}} = 0.225\\,\\mathrm{mmol/mL}$$\nThe required volume of the dose, $V_{\\text{dose}}$, is the total moles of calcium needed divided by the concentration of the calcium solution:\n$$V_{\\text{dose}} = \\frac{\\Delta M_{\\text{Ca,total}}}{C_{\\text{Ca}}} = \\frac{7.22\\,\\mathrm{mmol}}{0.225\\,\\mathrm{mmol/mL}} \\approx 32.088... \\,\\mathrm{mL}$$\nRounding the result to three significant figures as requested gives:\n$$V_{\\text{dose}} \\approx 32.1\\,\\mathrm{mL}$$",
            "answer": "$$\\boxed{32.1}$$"
        }
    ]
}